Page results
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Information about our UCLH Charity, charity funds and associated charities.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. Theseā¦
-
The Adult Acute speech and language therapist (SLTs) work across a range of acute hospital specialities.
File results
-
FOI/2023/0654 - Email encryption/ E-signature suppliers
-
FOI/2023/0655 - Customer Relationship Management (CRM) system
-
FOI/2023/0658 - Policies/procedures for Non-emergency patient transport services
-
FOI/2023/0662 - NEPTS and patient transport services
-
FOI/2023/0665 - Trust pathology services
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0675 - Number of cancer treatments at each stage
-
FOI/2023/0681 - Patient friends and family test supplier
-
FOI/2023/0713 - Administration of medicines policies